120 related articles for article (PubMed ID: 3386266)
1. 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor.
Giudici D; Ornati G; Briatico G; Buzzetti F; Lombardi P; di Salle E
J Steroid Biochem; 1988; 30(1-6):391-4. PubMed ID: 3386266
[TBL] [Abstract][Full Text] [Related]
2. 4-Aminoandrostenedione derivatives: a novel class of irreversible aromatase inhibitors. Comparison with FCE 24304 and 4-hydroxyandrostenedione.
Di Salle E; Giudici D; Ornati G; Briatico G; D'Alessio R; Villa V; Lombardi P
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):369-74. PubMed ID: 2257240
[TBL] [Abstract][Full Text] [Related]
3. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
Zaccheo T; Giudici D; Lombardi P; di Salle E
Cancer Chemother Pharmacol; 1989; 23(1):47-50. PubMed ID: 2491793
[TBL] [Abstract][Full Text] [Related]
4. Novel aromatase and 5 alpha-reductase inhibitors.
Di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T; Buzzetti F; Nesi M; Panzeri A
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):289-94. PubMed ID: 8043491
[TBL] [Abstract][Full Text] [Related]
5. Exemestane (FCE 24304), a new steroidal aromatase inhibitor.
di Salle E; Ornati G; Giudici D; Lassus M; Evans TR; Coombes RC
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):137-43. PubMed ID: 1525055
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and aromatase inhibition by potential metabolites of exemestane (6-methylenandrosta-1,4-diene-3,17-dione).
Buzzetti F; Di Salle E; Longo A; Briatico G
Steroids; 1993 Nov; 58(11):527-32. PubMed ID: 8273115
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biochemical studies of 7 alpha-substituted androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
Ebrahimian S; Chen HH; Brueggemeier RW
Steroids; 1993 Sep; 58(9):414-22. PubMed ID: 8236327
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
Numazawa M; Oshibe M; Yamaguchi S; Tachibana M
J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338
[TBL] [Abstract][Full Text] [Related]
10. Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione.
Brandt ME; Puett D; Covey DF; Zimniski SJ
J Steroid Biochem; 1988 Sep; 31(3):317-24. PubMed ID: 3419162
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione.
Takahashi M; Handa W; Umeta H; Ishikawa S; Yamashita K; Numazawa M
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):191-9. PubMed ID: 19520161
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.
Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH
Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic analysis of FCE 24304 (6-methylenandrosta-1,4-diene-3,17-dione) and FCE 24928 (4-aminoandrosta-1,4,6-triene-3,17-dione), two new aromatase inhibitors.
Del Nero S; Di Somma M; Vigevani A
J Chromatogr; 1992 Feb; 593(1-2):25-8. PubMed ID: 1639908
[TBL] [Abstract][Full Text] [Related]
14. 7alpha-Arylaliphatic androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
O'Reilly JM; Brueggemeier RW
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):93-102. PubMed ID: 9009242
[TBL] [Abstract][Full Text] [Related]
15. Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
Zaccheo T; Di Salle E
Cancer Chemother Pharmacol; 1989; 25(2):95-8. PubMed ID: 2513137
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
[TBL] [Abstract][Full Text] [Related]
17. Novel irreversible aromatase inhibitors.
di Salle E; Giudici D; Briatico G; Ornati G
Ann N Y Acad Sci; 1990; 595():357-67. PubMed ID: 2375613
[No Abstract] [Full Text] [Related]
18. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Covey DF; Hood WF
Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.
Li PK; Brueggemeier RW
J Med Chem; 1990 Jan; 33(1):101-5. PubMed ID: 2296006
[TBL] [Abstract][Full Text] [Related]
20. 7 alpha-substituted androstenediones as effective in vitro and in vivo inhibitors of aromatase.
Brueggemeier RW; Li PK; Snider CE; Darby MV; Katlic NE
Steroids; 1987; 50(1-3):163-78. PubMed ID: 3504058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
